Skip to main content

Table 2 Baseline clinical characteristics of all patients, and patients discriminated with the presence of late gadolinium enhancement (LGE) and segmental wall motion abnormality (SWMA)

From: Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study

  All patients (n = 86) LGE negative (n = 25) LGE positive (n = 61) p-value SWMA negative (n = 30) SWMA positive (n = 56) p-value
Demographics        
 Age, year 53 (42–61) 49 (42–59) 53 (42–63) 0.278 51 (42–59) 53 (42–62) 0.336
 Gender, female 39 (45) 15 (60) 24 (39) 0.131 20 (67) 19 (34) 0.007
Cardiovascular risk factors        
 Dyslipidemia 51 (59) 14 (56) 37 (61) 0.871 17 (57) 34 (61) 0.893
 Hypertension 34 (40) 7 (28) 27 (44) 0.247 10 (33) 24 (43) 0.529
 Diabetes 7 (8) 2 (8) 5 (8) 1.000 0 (0) 7 (13) 0.108
 Smoking 19 (22) 6 (24) 13 (21) 1.000 6 (20) 13 (23) 0.944
 Family risk for CAD 11 (13) 5 (20) 6 (10) 0.285 5 (17) 6 (11) 0.504
 Sum of risk factors 1 (1–2) 1 (0–2) 1 (1–2) 0.513 1 (1–2) 1 (1–2) 0.406
Symptoms        
 Syncope or presyncope 21 (24) 9 (36) 12 (20) 0.185 9 (30) 12 (21) 0.536
 Palpitation 34 (40) 13 (52) 21 (34) 0.204 14 (47) 20 (36) 0.448
 Chest pain 31 (36) 9 (36) 22 (36) 1.000 12 (40) 19 (34) 0.746
 NYHA-class 2 (1–3) 1 (1–2) 2 (1–4) 0.001 1 (1–2) 2 (1–4) 0.001
Congestive heart failure 38 (44) 4 (16) 34 (56) 0.002 2(7) 36 (64) < 0.001
Arrhythmias        
 Atrial fibrillation 25 (29) 6 (24) 19 (31) 0.688 5 (17) 20 (36) 0.109
 Ventricular fibrillation 9 (10) 3 (12) 6 (10) 0.715 3 (10) 6 (11) 1.000
 Sustained VT 9 (10) 1 (4) 8 (13) 0.274 1 (3) 8 (14) 0.152
 Nonsustained VT 16 (19) 6 (24) 10 (16) 0.542 5 (17) 11 (20) 0.962
Conducting abnormalities        
 AVB of any grade 39 (45) 7 (28) 32 (53) 0.067 9 (30) 30 (54) 0.062
 Distal AVB 7 (8) 3 (12) 4 (7) 0.409 3 (10) 4 (7) 0.691
Cardiac enzyme elevation* 32 (37) 8 (32) 24 (39) 0.693 9 (30) 23 (41) 0.436
  1. Values are median (IQR) or n (%).
  2. *Troponin T, Troponin I or CK-mb.
  3. Abbreviations: AVB atrioventricular block, CAD coronary artery disease, IQR interquartile range, LGE late gadolinium enhancement, NYHA-class New York Heart Association classification of functional capacity, SWMA segmental wall motion abnormality, VT ventricular tachycardia.